Technology
TECHNOLOGY OVERVIEW
At Stemedica, we believe that all stem cells are not created equal.
This belief is deeply rooted in more than thirty years of stem cell pioneering - from basic bench research to extensive clinical studies.
Through our patented and proprietary processes, we harvest the most viable cell colonies and manufacture them in a low oxygen environment, enabling us to yield larger quantities of product at the highest levels of quality and consistency. This process also enables our products to migrate, engraft and provide more measurable, efficacious results compared to other stem cells on the market. We have filed 18 patent applications - 17 that are published -- and are progressing with at least 6 more.
Our technology is one of the few licensed for clinical grade manufacturing and approved for clinical trial application by regulatory agencies in multiple countries.